AI assistant
Sending…
FREEPORT-MCMORAN INC — Director's Dealing 2021
May 12, 2021
30000_dirs_2021-05-12_919b5784-47d9-4d08-a939-658c30acf46e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FREEPORT-MCMORAN INC (FCX)
CIK: 0000831259
Period of Report: 2021-05-04
Reporting Person: Higgins Stephen T. (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 70000 | Direct |
| Common Stock | 16587 | Indirect |
| Common Stock | 18818 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units (cash-settled) | $ | Common Stock (10000) | Direct | ||
| Options (Right to Buy) | $46.73 | 2022-02-06 | Common Stock (45000) | Direct | |
| Options (Right to Buy) | $11.87 | 2029-02-05 | Common Stock (21667) | Direct | |
| Options (Right to Buy) | $11.91 | 2029-02-06 | Common Stock (65000) | Direct | |
| Options (Right to Buy) | $12.04 | 2030-02-04 | Common Stock (65000) | Direct | |
| Options (Right to Buy) | $28.14 | 2031-02-02 | Common Stock (15000) | Direct |
Footnotes
F1: Represents 70,000 stock-settled common stock restricted stock units.
F2: Balance as of 5/4/2021.
F3: Each cash-settled restricted stock unit is the economic equivalent of one share of the Issuer's common stock, payable in cash upon vesting.
F4: 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof.
F5: 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof.
F6: 100% vested on 2/6/2022
More from FREEPORT-MCMORAN INC
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 8
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Feb 27